And there’s a huge storm brewing for the FDA after going ahead and approving Remdesevir for in Hospital or high care setting use for those > 12 years or > 40 kgs with Covid. WHO informed Gilead on September 23rd of data they were about to publish showing no benefit! Now Gilead has been waved through and shown political preference because of their well connected high profile share holders. FDA behavior beggars belief
Cell Therapy News/Articles, page-7387
-
- There are more pages in this discussion • 11,051 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |